Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K
Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan.
Eur J Surg Oncol. 2017 Jun;43(6):1076-1082. doi: 10.1016/j.ejso.2017.03.021. Epub 2017 Apr 19.
The feasibility of salvage hepatectomy for locally recurrent hepatocellular carcinomas (HCCs) is unclear, especially for patients with viable parts of previously multinodular tumors.
We reviewed charts of patients who underwent initial hepatectomies between 2000 and 2014 to select those with local recurrences (LR) after non-surgical treatments. Their postoperative outcomes, including morbidity, recurrence-free survival (RFS), and overall survival (OS) were compared with matched patients who underwent initial hepatectomies for primary HCCs (PR). Their local recurrence patterns were divided into recurrent solitary tumors (Subgroup A); and recurrent parts of multinodular tumors (Subgroup B).
Among 664 patients, hepatectomy for LR was performed in 62 patients. Matched 59 patients were selected as PR. Clinicopathologic profiles at initial surgery were comparable between the LR and PR groups. Incidence of major morbidity (LR vs. PR, 7% vs. 5%, P = 1.00), 5-year RFS (21% vs. 37%, P = 0.28), and 5-year OS (69% vs. 69%, P = 0.62) were comparable. In the LR group, Subgroup B showed worse 5-year RFS (A vs. B, 29% vs. 0%, P < 0.01) and 5-year-OS (80% vs. 53%, P = 0.01). Postoperative recurrence occurred in 46 patients, but local and extrahepatic recurrence was seen only in 2 patients and 2 patients, respectively.
Salvage hepatectomy for locally recurrent HCCs is feasible, and results in prognosis comparable with hepatectomy for primary HCCs. Although the risk of postoperative recurrence was high in Subgroup B, rare local recurrence suggests the usefulness of salvaging uncontrolled tumor by nonsurgical treatment.
挽救性肝切除术治疗局部复发性肝细胞癌(HCC)的可行性尚不清楚,尤其是对于先前多结节肿瘤仍有存活部分的患者。
我们回顾了2000年至2014年间接受初次肝切除术患者的病历,以选择那些在非手术治疗后出现局部复发(LR)的患者。将他们的术后结果,包括发病率、无复发生存期(RFS)和总生存期(OS)与接受原发性HCC初次肝切除术(PR)的匹配患者进行比较。他们的局部复发模式分为复发性孤立肿瘤(A组);以及多结节肿瘤的复发部分(B组)。
在664例患者中,62例患者接受了LR肝切除术。选择59例匹配患者作为PR。LR组和PR组初次手术时的临床病理特征具有可比性。严重并发症发生率(LR组与PR组,7%对5%,P = 1.00)、5年RFS(21%对37%,P = 0.28)和5年OS(69%对69%,P = 0.62)具有可比性。在LR组中,B组的5年RFS(A组对B组,29%对0%,P < 0.01)和5年OS(80%对53%,P = 0.01)较差。46例患者术后复发,但仅分别有2例患者出现局部复发和肝外复发。
挽救性肝切除术治疗局部复发性HCC是可行的,其预后与原发性HCC肝切除术相当。尽管B组术后复发风险较高,但罕见的局部复发表明通过非手术治疗挽救未控制肿瘤是有用的。